Improvement in Intestinal-Failure-Associated Liver Disease by Using Parenteral Fish Oil as Monotherapy: Case-Based Review of the Literature

Intestinal-failure-associated liver disease (IFALD) is a common complication of prolonged parenteral nutrition (PN). Risk factors for IFALD include clinical features, as well medical interventions, and its management was initially based on the decrease or interruption while increasing enteral nutrition. However, tolerance full in children with intestinal failure may require rehabilitation over period years. As consequence, infants unable to wean from PN are prone develop end-stage disease. We describe case an infant receiving long-term who diagnosed wherein we were able reverse by switching lipid emulsions fish oil monotherapy. A systemic review reports series reversing using emulsion follows description.